Please wait a minute...
文章检索
预防医学  2024, Vol. 36 Issue (6): 518-522    DOI: 10.19485/j.cnki.issn2096-5087.2024.06.014
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
肥胖、外周血血脂指标与非小细胞肺癌的孟德尔随机化研究
白勇, 李萍, 姜楠
郑州大学第一附属医院呼吸内科,河南 郑州 450052
Associations of obesity and peripheral blood lipid indicators with non-small cell lung cancer: a Mendelian randomization study
BAI Yong, LI Ping, JIANG Nan
Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China
全文: PDF(786 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 采用孟德尔随机化(MR)方法探究肥胖、外周血血脂指标与非小细胞肺癌(NSCLC)的因果关系,为制定NSCLC防控策略提供依据。方法 通过全基因组关联研究(GWAS)及相关公开数据库收集体质指数(BMI)、体脂率(BFR)、腰臀比(WHR)3种肥胖评价指标,以及三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、载脂蛋白A1(ApoA1)、载脂蛋白B(ApoB)和脂蛋白a[LP(a)]7种外周血血脂指标资料,采用随机效应模型的逆方差加权法和多因素MR分析肥胖、外周血血脂指标与NSCLC的因果关系。采用Cochran Q检验和MR-Egger回归法评估工具变量的异质性和水平多效性。结果 BMI与NSCLC存在统计学关联(OR=1.256,95%CI:1.087~1.451);BFR、WHR及7种外周血血脂指标与NSCLC无统计学关联(均P>0.005)。BMI、BFR、WHR、TG、HDL-C与NSCLC的关联存在异质性(均P<0.05);未发现工具变量的水平多效性(均P>0.05)。调整BFR后,BMI与NSCLC无统计学关联(OR=1.367,95%CI:0.878~2.128);分别调整WHR、外周血血脂指标后,BMI与NSCLC仍有统计学关联(均P<0.05)。结论 BMI升高与NSCLC发病风险升高有关,BFR是BMI与NSCLC关联的潜在影响因素。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
白勇
李萍
姜楠
关键词 肥胖血脂非小细胞肺癌关联体质指数体脂率    
AbstractObjective To examine the causal relationships between obesity, peripheral blood lipid indicators and non-small cell lung cancer (NSCLC) using Mendelian randomization (MR) method, so as to provide the basis for developing NSCLC prevention and control strategies. Methods Genetic variation data of three obesity evaluation indicators, including body mass index (BMI), body fat ratio (BFR) and waist-to-hip ratio (WHR), and seven peripheral blood lipid indicators, including triglyceride (TG), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), apolipoprotein A1 (ApoA1), apolipoprotein B (ApoB) and lipoprotein a [LP (a)] were collected through genome-wide association studies (GWAS) and related public databases. Potential causal relationships between obesity, peripheral blood lipid indicators and NSCLC were analyzed using inverse-variance weighted (IVW) method and multivariable MR analysis upon a random effect model. Heterogeneity and horizontal pleiotropy of instrumental variables were evaluated using Cochran's Q test and MR-Egger regression. Results There was statistically association between BMI with NSCLC (OR=1.256, 95%CI: 1.087-1.451); there were no statistically associations between BFR, WHR, seven peripheral blood lipid indicators and NSCLC (all P>0.005). There was heterogeneity in the association between BMI, BFR, WHR, TG, HDL-C and NSCLC (all P<0.05); no horizontal pleiotropy of instrumental variables was found (all P>0.05). There was no statistically association between BMI and NSCLC after adjusting BFR (OR=1.367, 95%CI: 0.878-2.128); there was still statistically association between BMI and NSCLC after adjusting WHR and peripheral blood lipid indicators (both P<0.05). Conclusions The increase of BMI is associated with the increased risk of NSCLC incidence. BFR may be a potential influencing factor for the association between BMI and NSCLC.
Key wordsobesity    blood lipid    non-small cell lung cancer    association    body mass index    body fat rate
收稿日期: 2023-12-04      修回日期: 2024-03-22      出版日期: 2024-06-10
基金资助:河南省医学科技攻关计划项目(2018020097)
作者简介: 白勇,硕士,副主任医师,主要从事肺癌等呼吸疾病的诊疗工作,E-mail:rain20220202@126.com
引用本文:   
白勇, 李萍, 姜楠. 肥胖、外周血血脂指标与非小细胞肺癌的孟德尔随机化研究[J]. 预防医学, 2024, 36(6): 518-522.
BAI Yong, LI Ping, JIANG Nan. Associations of obesity and peripheral blood lipid indicators with non-small cell lung cancer: a Mendelian randomization study. Preventive Medicine, 2024, 36(6): 518-522.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2024.06.014      或      https://www.zjyfyxzz.com/CN/Y2024/V36/I6/518
[1] CHEN P X,LIU Y H,WEN Y K,et al.Non-small cell lung cancer in China[J].Cancer Commun(Lond),2022,42(10):937-970.
[2] NITSCHE L J,MUKHERJEE S,CHERUVU K,et al.Exploring the impact of the obesity paradox on lung cancer and other malignancies[J/OL].Cancers(Basel),2022,14(6)[2024-03-22].https://doi.org/10.3390/cancers14061440.
[3] TEN HAAF K,JEON J,TAMMEMAGI M C,et al.Risk prediction models for selection of lung cancer screening candidates:a retrospective validation study[J/OL].PLoS Med,2017,14(4)[2024-03-22].https://doi.org/10.1371/journal.pmed.1002277.
[4] PICHÉ M E,TCHERNOF A,DESPRÉS J P.Obesity phenotypes,diabetes,and cardiovascular diseases[J].Circ Res,2020,126(11):1477-1500.
[5] TURNER D P,HOULE T T.Observational study designs[J].Headache,2019,59(7):981-987.
[6] 董娅,王浩澄,单东凤,等.血脂水平与肺癌风险及预后相关性的研究进展[J].中国肺癌杂志,2020,23(9):824-829.
[7] SANDERSON E,GLYMOUR M M,HOLMES M V,et al.Mendelian randomization[J/OL].Nat Rev Methods Primers,2022,2[2024-03-22].https://doi.org/10.1038/s43586-021-00092-5.
[8] YENGO L,SIDORENKO J,KEMPER K E,et al.Meta-analysis of genome-wide association studies for height and body mass index in ~700 000 individuals of European ancestry[J].Hum Mol Genet,2018,27(20):3641-3649.
[9] BARTON A R,SHERMAN M A,MUKAMEL R E,et al.Whole-exome imputation within UK Biobank powers rare coding variant association and fine-mapping analyses[J].Nat Genet,2021,53(8):1260-1269.
[10] RICHARDSON T G,SANDERSON E,PALMER T M,et al.Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease:a multivariable Mendelian randomisation analysis[J/OL].PLoS Med,2020,17(3)[2024-03-22].https://doi.org/10.1371/journal.pmed.1003062.
[11] KURKI M I,KARJALAINEN J,PALTA P,et al.FinnGen provides genetic insights from a well-phenotyped isolated population[J].Nature,2023,613(7944):508-518.
[12] ZHANG W M,GHOSH D.A general approach to sensitivity analysis for Mendelian randomization[J].Stat Biosci,2021,13(1):34-55.
[13] OSWALT C,LIU Y Z,PANG H,et al.Associations between body mass index,weight loss and overall survival in patients with advanced lung cancer[J].J Cachexia Sarcopenia Muscle,2022,13(6):2650-2660.
[14] 林秀琴,徐健,许树红,等.ADH、ALDH基因多态性与饮酒的交互作用对肺癌的影响研究[J].预防医学,2021,33(10):1022-1025,1029.
[15] 孙霞,朱艳,郑鹏,等.超重肥胖和2型糖尿病对瘦素、内脂素的影响研究[J].预防医学,2022,34(6):581-585.
[16] ARORA H,COLLAZO I,EISERMANN J,et al.Association between MitoScore,BMI,and body fat percentage as a predictive marker for the outcome of in-vitro fertilization(IVF)[J/OL].Cureus,2022,14(7)[2024-03-22].https://doi.org/10.7759/cureus.27367.
[1] 高慧, 谢亮, 姚春阳, 王林红, 金鎏, 胡洁. 血脂异常患者社区综合管理模式的干预效果评价[J]. 预防医学, 2026, 38(1): 15-19.
[2] 郭艳强, 张丽, 张兰, 韩荣荣. 高血压患者肥胖类型与动脉粥样硬化性心血管疾病风险的关系研究[J]. 预防医学, 2026, 38(1): 36-42.
[3] 贾梦涵, 陈培, 李鑫, 孙玲. 食品环境与肥胖的相关性研究进展[J]. 预防医学, 2026, 38(1): 43-47.
[4] 高雷, 叶真, 王玮, 赵栋, 徐沛维, 章荣华. 生命早期肥胖原暴露与儿童肥胖关系的研究进展[J]. 预防医学, 2026, 38(1): 48-54.
[5] 王芸, 申赟魁, 刘博昊, 陈静, 张琨. 延庆区中小学生近视与超重肥胖共患现况调查[J]. 预防医学, 2026, 38(1): 85-88.
[6] 陆杰, 张柯, 吴雅, 王玥, 张玥, 陆叶, 吴周理, 任志华, 黄艺文. 肥胖指标预测2型糖尿病患者心脑血管疾病的效果比较[J]. 预防医学, 2025, 37(9): 886-891.
[7] 张一, 李梦迪, 石亚锋, 苗超. 余姚市中小学生超重和肥胖现况调查[J]. 预防医学, 2025, 37(9): 955-958.
[8] 周梦怡, 苏丹婷, 何梦洁, 徐沛维, 韩丹, 黄李春, 章荣华. 植物性饮食与不同肥胖类型的关联研究[J]. 预防医学, 2025, 37(8): 773-778.
[9] 成灵灵, 阎亚琼, 白增华, 张晓刚, 郝丽婷, 杨慧莹. 先天性甲状腺功能减退症患儿年龄别体质指数Z评分变化轨迹及影响因素[J]. 预防医学, 2025, 37(8): 858-863.
[10] 黄阳梅, 沈旭娟, 谢董颖, 张琦, 郑子聪, 王勐. 小学生体重监测信息反馈干预的效果评价[J]. 预防医学, 2025, 37(6): 541-545.
[11] 蒋安然, 朱煜典, 鲁芬, 方大春, 翟光富. 膳食行为与中学生超重肥胖的关联研究[J]. 预防医学, 2025, 37(4): 341-345.
[12] 江南, 唐晓敏, 孙文韬. 膳食模式与中小学生超重肥胖的关联研究[J]. 预防医学, 2025, 37(3): 228-232.
[13] 陈海苗, 马岩, 刘明奇, 马珊珊, 李军, 方益荣. 儿童期肥胖与2型糖尿病、冠心病的孟德尔随机化研究[J]. 预防医学, 2025, 37(3): 307-311.
[14] 米孝濛, 熊苏婷, 徐文国, 徐文超. 常州市35岁及以上居民血脂异常调查[J]. 预防医学, 2025, 37(2): 173-177.
[15] 吴梓敬, 李纪新, 邱林杰, 任燕, 李美洁, 邹姹姹, 张晋. 身体形态指数和身体圆度指数预测非肥胖人群非酒精性脂肪性肝病的效果比较[J]. 预防医学, 2025, 37(12): 1222-1227.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed